GAMMA Investing’s Spyre Therapeutics SYRE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$2.61K	Sell	174 -96	-36%	-$1.44K	﹤0.01%	3327
2025 Q1	$4.36K	Buy	+270	New	+$4.36K	﹤0.01%	3138
2024 Q4	–	Sell	-5	Closed	-$147	–	3825
2024 Q3	$147	Buy	+5	New	+$147	﹤0.01%	3541